Evolus (NASDAQ:EOLS) reported quarterly earnings of $0.00 per share which missed the analyst consensus estimate of $0.05 by 98 percent. This is a 97.5 percent decrease over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $90.300 million which beat the analyst consensus estimate of $89.667 million by 0.71 percent. This is a 14.38 percent increase over sales of $78.947 million the same period last year.